glp 1 agonist mechanism of action weight loss GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Mechanism of action of GLP-1

Description

The once-monthly race Three serious entrants are now in clinical development for monthly GLP-1-class obesity drugs

GLP-1s like Wegovy and Mounjaro have four mechanisms to improve blood sugar levels and support weight loss: Improve insulin function: Improving insulin response to glucose from meals enables the body to move glucose from the blood and into the cells (like muscle cells) to be burnt for energy or stored as glycogen

doi: 10.1371/journal.pone.0195123

GLP-1 drugs are also showing promise for many other conditions, including fatty liver disease

Some physicians prescribe it longer, and research supports extended use in certain cases, but the fundamental problem remains: phentermine is fighting your biology with a blunt instrument, and your biology eventually fights back